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Abstract
Background: Report a nationwide epidemic of Shiga toxin-producing E. coli (STEC) O103:H25 causing hemolytic
uremic syndrome (D+HUS) in children.
Methods: Description of clinical presentation, complications and outcome in a nationwide outbreak.
Results: Ten children (median age 4.3 years) developed HUS during the outbreak. One of these was presumed to
be a part of the outbreak without microbiological proof. Eight of the patients were oligoanuric and in need of
dialysis. Median need for dialysis was 15 days; one girl did not regain renal function and received a kidney
transplant. Four patients had seizures and/or reduced consciousness. Cerebral oedema and herniation caused the
death of a 4-year-old boy. Two patients developed necrosis of colon with perforation and one of them developed
non-autoimmune diabetes.
Conclusion: This outbreak of STEC was characterized by a high incidence of HUS among the infected children,
and many developed severe renal disease and extrarenal complications. A likely explanation is that the O103:H25
(eae and stx2-positive) strain was highly pathogen, and we suggest that this serotype should be looked for in
patients with HUS caused by STEC, especially in severe forms or outbreaks.
Background
Haemolytic uremic syndrome (HUS) is a severe, acute
and dramatic disease affecting previously healthy chil-
dren. HUS is defined as a triad of acute kidney injury,
microangiopatic haemolytic anaemia and thrombocyto-
penia in patients with no other explanation for coagulo-
pathy [1] e.g. thrombotic thrombocytopenic purpura.
More than 90% of the cases are due to Shiga toxin-pro-
ducing E. coli (STEC) infections; termed typical HUS or
diarrhoea associated HUS (D+HUS). Many different sero-
types can cause HUS, the most prevalent in Europe and
USA being O157:H7 [2,3]. A broad spectrum of extrare-
nal complications may occur in HUS, the most common
are gastrointestinal and cerebral. Extrarenal involvement
at an early stage is associated with increased morbidity
and mortality. Although several epidemics, caused by
O157 [4] and other serotypes [5] have been reported, the
majority of HUS cases appear sporadic or in small clus-
ters [1].
In 2006 a nationwide outbreak of STEC-infections
took place in Norway. Totally 17 cases (16 children and
one adult) were identified during the outbreak, all
caused by a rare variant (O103:H3, eae and stx2-posi-
tive). Some microbiological, serological and epidemiolo-
gical aspects of the outbreak have previously been
reported [6,7]. In this article we will focus on those chil-
dren that presented with typical HUS since the clinical
course was characterized by an aggressive disease with
significant extrarenal complications.
Methods
Within a short period of time from 30th of January to
13th of March 2006 a nationwide outbreak of STEC
-infections occurred. As soon as the epidemic pattern
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was confirmed, health personnel were informed by the
National health authorities, and instructed to collect fae-
cal samples on all suspected cases with possible HUS-
related E. coli infection (diarrhoea and fever). At the
same time microbiological laboratories were instructed
to investigate specifically for serotype O103.
Clinical data of the children were retrieved from medi-
cal notes and charts. All five university-hospitals in Nor-
way treating children with HUS were contacted, and a
review of all admissions were done at each department
to ensure all cases being included
Results
Sixteen children were infected by E. coli O103:H25 during
the outbreak. Ten of these children (six girls and four
boys), with a median age of 4.3 years (range 1.8-8.5), were
admitted to hospital with the clinical picture of typical D+
HUS and constitute our study population. The children
were living widely spread, and were admitted to the depart-
ment of paediatrics at four different University Hospitals
with a median time of symptoms of 5 days (range 2-10).
Presentation on admission
Eight of the ten children were severely affected with
bloody diarrhoea when admitted to hospital. Eight
patients were oligoanuric with urine output less than 0.5
mL/kg/h. Elevated serum creatinine, leukocytosis,
thrombocytopenia, elevated lactate dehydrogenase (LD)
and hyponatremia (nine out of ten) were common find-
ings (Table 1). The haemoglobin values on admission
varied, but all patients developed marked haemolytic
anaemia during their first week in hospital and received
blood transfusion, the indication being respiratory com-
promise or severe anaemia (Table 1).
Renal complications and outcome
Eight patients required dialysis (Table 2). Haemodialysis
was chosen in four children, in three cases based on the
severity of abdominal pain and activity of enterocolitis
and in one case due to recent abdominal surgery. Peri-
toneal dialysis was chosen in four children with less
severe abdominal symptoms on admission. However, in
two of these patients intestinal perforation occurred and
peritoneal dialysis were therefore switched to haemodia-
lysis. The median time on dialysis was 15 days (3 days -
> 1 year), or 14 days (3-34 days) excluded the patient
who developed ESRF and later had a kidney transplant.
On follow up one year after diagnosis, four patients had
regained normal renal function and normal blood pres-
sure, and four patients had low-grade proteinuria and/or
microscopic haematuria, but no hypertension, defined as
blood-pressure above the 95th percentile for age, sex
and height. Patient number 9 developed end stage renal
failure and was on dialysis until she received a living
related kidney transplant 12 months after her first
symptoms.
Extrarenal complications
Five of the children had signs of CNS involvement
(Table 2). One boy died three days after admission of
cerebral herniation. Cerebral magnetic resonance ima-
ging (MRI) showed generalised oedema and bilateral
infarcts in the basal gangliae. Four patients presented
cerebral seizures and/or reduced consciousness (Table
2). One of these had a unilateral infarction in the area
of putamen on cerebral MRI. He recovered and neurolo-
gical examination on discharge was completely normal.
The other patients with cerebral symptoms had normal
MRI-findings.
Table 1 Laboratory values for ten patients with HUS caused by E. coli O103:H25
Patient Haemoglobin Creatinine Lactate dehydrogenase Thrombocytes Leucocytes Sodium
No (g/dL) (μmol/L) (U/L) (× 109/L) (× 109/L) (mmol/L)
Admission Min. Admission Max. Admission Max. Admission Min. Admission Admission
1 7.6 5.7 461 492 2888 2888 43 29 9.1 132
2 9.3 7.7. 82 162 2241 3575 17 16 7.1 137
3 11.5 7.5 196 407 3888 3888 84 62 33.8 128
4 11.2 6.5 231 358 3827 4287 41 41 16.5 132
5 9.5 7.6 627 673 3803 3803 61 23 33.7 133
6 9.1 7.1 421 658 4036 4036 60 60 21.0 127
7 12.2 5.5 143 422 764 3212 134 67 30.0 132
8 16.9 8.8 107 276 2641 3431 61 35 41.3 121
9 12.5 7.6 153 405 2419 2928 110 66 35.3 127
10 6.1 5.4 84 84 2566 2566 109 107 25.4 125
Median 10.4 7.3 175 406 2764 3503 61 51 27.7 130
HUS: Haemolytic uremic syndrome
Min: Minimal level
Max: Maximal level.
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Appendectomy was performed in one girl in a local
hospital before the HUS diagnosis was established. The
removed appendix was not inflamed. Two patients
developed necrosis of colon with perforation and under-
went laparotomy on hospital day 6 (left hemicolectomy)
and day 24 (subtotal colectomy), respectively. One
patient developed permanent insulin dependent diabetes
mellitus with negative anti-GAD antibodies, and another
had transient hyperglycaemia with the need of insulin-
infusion for five days.
Antibiotics
Seven patients were treated with antibiotics. In patient 6
antibiotics was started at the local hospital because of
suspected sepsis 6 hours prior to the diagnosis of HUS,
although presenting with bloody stools, anuria and
thrombocytopenia (Table 1). The remaining six children
who received systemic antibiotics, all started treatment
at least three days after the diagnosis of HUS was estab-
lished. In three children (patients 3, 4 and 9) antibiotics
were administered in the peritoneal dialysis fluid on the
assumption of peritonitis. Bacterial cultures were later
proven negative. Five patients were given antibiotics
intravenously, for suspected sepsis (patient 2, 8 and 9),
perforation of colon (patient 4 and 9) or catheter related
infection (patient 5), respectively.
Microbiology
In eight of ten patients who developed HUS, specific
IgG antibodies against O103 were detected. In four of
the patients, O103:H25 was found in faecal samples.
The bacteria were also found in faecal samples from six
children who did not develop HUS. In one boy (patient
1) faecal samples could not be collected, and IgG anti-
bodies against O103 were not detected. We have
included this patient in the report based on the fact that
he had eaten the specific smoked sausage and was the
first reported case in the outbreak [6].
Discussion
We present a nationwide outbreak of STEC causing
severe HUS in a high percentage of the affected chil-
dren. The clinical course was characterized by an
aggressive disease with significant extrarenal complica-
tions. In Norway there are five University Hospitals with
paediatric departments, all in close contact with the
local paediatric departments. Due to the alert of the out-
break, the University Hospitals were contacted to treat
all cases of HUS. The affected children were admitted to
four of these departments, the 5th department confirm-
ing that no patient with HUS was admitted during the
outbreak. Therefore we conclude our material includes
all the affected children.
Table 2 Mode of dialysis, acute symptoms and complications in ten patients with D+HUS caused by E. coli O103:H25
Patient Dialysis Neurological Gastrointestinal Others
No Mode Symptoms MRI/CT
Duration
(Days)
1 HD 7 - - - -
2 - - - - - -
3 PD 15 Reduced consciousness MRI: Infarction basal ganglia - -
4 PD/
HD*
15 - - Perforation of colon -
5 HD 13 Reduced consciousness CT normal - -
6 PD 34 Generalised seizures before
admission
MRI normal (8 months after) - -
7 HD 14 - - Laparoscopy: suspect
appendicitis
Insulin for 5
days
8 HD 3 Death due to fatal cerebral
oedema
CT/MRI: generalised oedema, infarction of
basal ganglia
- -
9 PD/
HD*
∞ Reduced consciousness and
seizures
CT/MRI normal Colon necrosis Diabetes
mellitus
10 - - - - - -
*Switched to HD because of intestinal perforation
HUS: Haemolytic uremic syndrome
MRI: magnetic resonance imaging
CT: Computer tomography
HD: haemodialysis
PD: Peritoneal dialysis.
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Several clinical and biochemical features at onset of
HUS have been proposed to be related to poor prog-
nosis [8]. Among the most often proposed factors are
leukocytosis and anuria [9-11]. A case-control study
from 2006 dealt with 17 deaths among patients with
HUS and concluded that those presenting with oligoa-
nuria, dehydration, WBC > 20 × 109/L and haematocrit
> 23% are at substantial risk of fatal HUS [12]. Most of
the patients in our material (seven of 10) had white
blood count above 20 × 109/L on admission; the highest
level (41.3 × 109/L) was registered in the boy who died.
He also had the highest haemoglobin-level and thereby
haematocrit, corresponding well with the risk-factors
pointed out by Oakes et al. [12]. Eight of ten patients
were oligoanuric on admission.
Seven of the children needed transient dialysis, with a
median duration of 15 days. One patient developed end
stage renal failure and received a living related kidney
transplant one year later. According to the literature,
around half of children with HUS will need dialysis,
with a median duration of 5 to 7 days [13]. This epi-
demic shows a higher proportion of patients developing
a very severe disease with extrarenal complications.
CNS involvement is common and is reported in 20-
50% of HUS cases [14,15] and was present in five
patients in our material. Common signs of CNS involve-
ment in HUS are seizures, reduced level of conscious-
ness, hemiparesis, visual disturbances and brain stem
symptoms. Basal ganglia involvement is a typical MRI-
finding in HUS-patients with neurological complications
[15], and was present in two of our patients (Table 2).
The reported incidence of colon necrosis and perfora-
tion in case studies varies from 1-8% [16-19]. A review
by Siegler in 1994 reported a total incidence of colon
necrosis/perforation at 2% [14]. Two of the patients in
the present study developed necrosis of colon (20%).
Patient 9 underwent subtotal colectomy 27 days after
onset of symptoms. In a paper reviewing the occurrence
of colonic necrosis in patients with HUS, a mean of 11
days after onset of symptoms was reported [18]. Both
our patients were on peritoneal dialysis when the necro-
sis occurred. To our knowledge peritoneal dialysis being
a risk factor for the development of colonic necrosis in
patients with HUS has not been reported. However,
peritoneal dialysis may mask abdominal symptoms lead-
ing to delay in diagnosis and surgical treatment.
Diabetes mellitus is a rare complication of HUS and
mainly occurs in severe cases [19]. A systematic review
of 21 studies concluded a pooled incidence of 3.2% [20].
Autopsy studies have shown thrombosis of the vessels
supplying the islets of Langerhans with preservation of
the exocrine pancreas [21]. One girl (patient 9) devel-
oped permanent insulin-dependent diabetes mellitus.
There was no evidence of autoimmune diabetes as all
diabetes related autoantibodies were negative. She was
seriously ill on admission and developed necrosis of
colon and end stage renal failure, and finally received a
kidney transplant. This corresponds to a previous
review, stating that children with HUS who develop dia-
betes mellitus, were more likely to have severe disease
with increased mortality risk [20]. Among survivors,
38% were left with permanent diabetes requiring insulin
[20]. Even though this patient also needed a kidney
transplant, simultaneous pancreas and kidney transplan-
tation was not an option, due to our policy to use living
related donors which favourably influence outcome.
All children received blood transfusions. The mean
haemoglobin-value at transfusion was 6.9 g/dL. Erythro-
cyte transfusions in HUS should be avoided if possible,
and some suggest it is indicated only when haemoglobin
is below 6.0 g/dL [22]. Nevertheless, the usual indica-
tions for erythrocyte transfusions apply, i.e. respiratory
compromise and cerebral involvement, and 70-80% of
patients with HUS will require transfusions [1,23].
Antibiotics is contraindicated in the treatment of pos-
sible STEC infections, due to increased toxin-release
from bacterial lysis [24] or increased production of
toxin due to induction of bacteriophages on which stx-
genes are located [25]. In our material, six children
received intravenous antibiotics. However, the treatment
was initiated after the diagnosis of HUS was established
in five, and none of the patients had antibiotics started
as treatment of HUS, but on the suspicion of secondary
bacterial infections.
To our knowledge this is the first outbreak of HUS
caused by E. coli O103. The microbiological, serological
and epidemiological aspects of the outbreak have pre-
viously been published [6,7]. We found positive faecal
samples for O103:H25 in ten children during the out-
break, and four of these developed HUS. This high inci-
dence of HUS among the infected patients contrasts
previous reports on E. coli O157:H7 outbreaks, in which
11%-14% developed HUS [26,27]. During the present
outbreak, the attention-level in the population was kept
high due to huge interest of the epidemic in the media.
National health authorities instructed parents to see a
physician if their child had any symptoms of diarrhoea
or vomiting. Physicians were informed by the Norwe-
gian Institute of Public Health to collect faecal samples
from children with diarrhoea and the number of faecal
samples analyzed by the microbiological laboratories
increased. On that background it is unlikely that the
number of children infected by this specific O103-strain
was substantially higher than those diagnosed. The spe-
cific diagnosis of O103 was confirmed either through
faecal sampling or serology in nine out of ten patients.
This corresponds to Lynn et al. who found that 84% of
the cases of HUS in UK and Ireland in 1997-2001 were
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similarly confirmed [2]. In the present report positive
faecal samples were found in only four of the patients
with HUS. The explanation to this might partially be
due to difficulties collecting adequate samples; several of
the children did not pass stool for several days after
admission to hospital. In a prospective surveillance of
Canadian children with HUS from 2000 to 2002, stool
cultures showed evidence of bacterial pathogens in 67%
of the patients, but only two non-O157-strains were
found [28].
Conclusion
This outbreak of colitis caused by STEC serotype O103:
H25 (eae and stx2-positive) was characterized by a very
high incidence of HUS, and the majority of the affected
children experienced severe renal disease and significant
extrarenal complications. Although genetic variability
theoretically could explain Norwegian children being
more prone to severe disease, we suggest that STEC ser-
otype O103:H25 (eae and stx2-positive) may be highly
pathogenic and should be investigated for in future HUS
outbreaks.
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